These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21195927)

  • 41. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
    Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
    Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers.
    Xita N; Papassotiriou I; Georgiou I; Vounatsou M; Margeli A; Tsatsoulis A
    Metabolism; 2007 Jun; 56(6):766-71. PubMed ID: 17512308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation.
    Stenvinkel P
    J Ren Nutr; 2011 Jan; 21(1):82-6. PubMed ID: 21195926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology.
    Beige J; Heipmann K; Stumvoll M; Körner A; Kratzsch J
    Expert Opin Ther Targets; 2009 Feb; 13(2):163-73. PubMed ID: 19236235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Benedetto FA; Cutrupi S; Parlongo S; Malatino LS; Bonanno G; Seminara G; Rapisarda F; Fatuzzo P; Buemi M; Nicocia G; Tanaka S; Ouchi N; Kihara S; Funahashi T; Matsuzawa Y
    J Am Soc Nephrol; 2002 Jan; 13(1):134-141. PubMed ID: 11752030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Leptin-to-adiponectin ratio as a new marker associated with metabolic disease].
    Kotani K; Sakane N
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():540-3. PubMed ID: 17458278
    [No Abstract]   [Full Text] [Related]  

  • 47. The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients.
    Markaki A; Kyriazis J; Stylianou K; Fragkiadakis GA; Perakis K; Margioris AN; Ganotakis ES; Daphnis E
    PLoS One; 2012; 7(12):e52350. PubMed ID: 23285003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adiponectin and end-stage renal disease.
    Markaki A; Psylinakis E; Spyridaki A
    Hormones (Athens); 2016 Jul; 15(3):345-354. PubMed ID: 27838604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adiponectin is unrelated to kidney function or injury markers in renal transplant recipients: A one-year follow-up study.
    Serwin N; Adamiak D; Wiśniewska M; Marchelek-Myśliwiec M; Serwin K; Cecerska-Heryć E; Grygorcewicz B; Roszak M; Miądlicki K; Dołęgowska B
    Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106618. PubMed ID: 35007702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discriminatory Value of Adiponectin to Leptin Ratio for COVID-19 Pneumonia.
    Tonon F; Di Bella S; Giudici F; Zerbato V; Segat L; Koncan R; Misin A; Toffoli B; D'Agaro P; Luzzati R; Fabris B; Bernardi S
    Int J Endocrinol; 2022; 2022():9908450. PubMed ID: 35529082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adiponectin as a therapeutic target for diabetic foot ulcer.
    Abdalla MMI; Mohanraj J; Somanath SD
    World J Diabetes; 2023 Jun; 14(6):758-782. PubMed ID: 37383591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adiponectin in renal fibrosis.
    Jing H; Tang S; Lin S; Liao M; Chen H; Fan Y; Zhou J
    Aging (Albany NY); 2020 Feb; 12(5):4660-4672. PubMed ID: 32065783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epicardial Adipose Tissue, Adiponectin and Leptin: A Potential Source of Cardiovascular Risk in Chronic Kidney Disease.
    D'Marco L; Puchades MJ; Gorriz JL; Romero-Parra M; Lima-Martínez M; Soto C; Bermúdez V; Raggi P
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physical Activity in the Prevention of Development and Progression of Kidney Disease in Type 1 Diabetes.
    Pongrac Barlovic D; Tikkanen-Dolenc H; Groop PH
    Curr Diab Rep; 2019 May; 19(7):41. PubMed ID: 31152254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.
    Spyrou N; Avgerinos KI; Mantzoros CS; Dalamaga M
    Curr Obes Rep; 2018 Dec; 7(4):260-275. PubMed ID: 30145771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis.
    Li J; An C; Kang L; Mitch WE; Wang Y
    Adv Chronic Kidney Dis; 2017 May; 24(3):150-153. PubMed ID: 28501077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Bone Marrow-Derived Fibroblasts in Renal Fibrosis.
    Yan J; Zhang Z; Jia L; Wang Y
    Front Physiol; 2016; 7():61. PubMed ID: 26941655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort.
    Cao X; Zhou J; Yuan H; Wu L; Chen Z
    BMC Nephrol; 2015 Jun; 16():85. PubMed ID: 26084279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability.
    D'Marco L; Bellasi A; Raggi P
    Dis Markers; 2015; 2015():586569. PubMed ID: 25944976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obesity, oxidative stress, and fibrosis in chronic kidney disease.
    Sharma K
    Kidney Int Suppl (2011); 2014 Nov; 4(1):113-117. PubMed ID: 25401040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.